A close-up shot at two hands holding a syringe that is inserted in a vial of medication.

Medication

Marcus Institute research is optimizing the benefits of pharmaceutical treatments for older patients while ensuring safety.

Improving Medication Safety for Older Adults

People 65 and older take prescribed medications more frequently than any other age group in the United States. Almost nine out of ten older adults take at least one medication, and more than half report that they take four or more prescription drugs. 

Advances in effective therapies for preventing and curing disease have contributed significantly to longevity and wellness. 

At the same time, it’s important to recognize that our bodies process medications differently as we age and medication doses are mostly established in studies done on younger, healthier adults, which means that older patients may be at risk when prescribed certain medications at doses designed for younger people.

That’s why Marcus Institute researchers are examining:

  • The relationship between medications and adverse health outcomes such as falls, injuries, and treatment side effects among older people
  • The efficacy of deprescribing medications for older people
  • The ways that genetics can influence our response to medications
  • How certain supplements can improve or prevent conditions common in aging

The Marcus Institute’s Findings on Medication Use in Elderly Patients

Using real-world databases including Medicare claims and the Minimum Data Set, Marcus Institute researchers have:

  • Investigated the relationship of many classes of medications to adverse health outcomes
  • Gained understanding through observational studies and clinical trials of the risks and benefits of deprescribing, which is the intentional reduction or stopping of medications that might be causing harm or might not be beneficial

Research currently in progress includes:  

  • An innovative pilot program to encourage deprescribing in nursing home residents 
  • Clinical trials of probiotic and prebiotic supplements to prevent bone loss 
  • A study of drugs that can enhance cerebral blood flow, including senolytic agents, to improve executive cognitive function and the central nervous system’s control of mobility 

Medication is a critical component of medical treatment and Marcus Institute researchers are working to make sure these life-saving therapies do just that and don’t cause more harm than good.

Explore this section to learn more about the Marcus Institute’s research into the safe and effective use of medications in older adults.

Find current research projects

Showing 10 Results

Utilization and Clinical Outcomes of Left Atrial Appendage Occlusion in Older Adults with Atrial Fibrillation and Frailty

The research aims to evaluate the effectiveness and safety of left atrial appendage occlusion device compared with direct oral anticoagulants in older adults with atrial fibrillation. 

R01 HL175560  

Principal Investigator

Related News